Faia, K., White, K., Murphy, E., Proctor, J., Pink, M., Kosmider, N., . . . Kutok, J. (2018). The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies. PLoS One.

Faia, Kerrie, Kerry White, Erin Murphy, Jennifer Proctor, Melissa Pink, Nicole Kosmider, Karen McGovern, a Jeffery Kutok. "The Phosphoinositide-3 Kinase (PI3K)-δ,γ Inhibitor, Duvelisib Shows Preclinical Synergy With Multiple Targeted Therapies in Hematologic Malignancies." PLoS One 2018.

Faia, Kerrie, et al. "The Phosphoinositide-3 Kinase (PI3K)-δ,γ Inhibitor, Duvelisib Shows Preclinical Synergy With Multiple Targeted Therapies in Hematologic Malignancies." PLoS One 2018.